Over the last few decades, advocates have given voice to the challenges that women face, including disparities in access to healthcare and representation. Today, women tend to be the primary healthcare decision makers for themselves and their households. We’ve seen that new technologies, both digital and device, have the ability to positively impact and empower women’s health across their care journey, including birth control, menopause, menstrual care, clinical trial enrollment, and more. Our TMCx portfolio is home to several companies impacting fertility (Kegg) and pre- and postpartum care (BabyScripts). We are seeking to work with companies that are innovating in this Women’s Health and are giving women and their providers opportunity to improve health and outcomes.
Texas Medical Center Innovation has opened applications for TMCx, a medical device and digital health accelerator focused on building clinical partnerships. Through TMCx, companies access clinical champions and stakeholders across the TMC campus. Participating companies develop relationships with health systems toward development of a pilot, clinical study, or joint development agreement. Discover more here.
Written in collaboration with Anna Vu.